| 000 | 01348 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513123803.0 | ||
| 264 | 0 | _c19980108 | |
| 008 | 199801s 0 0 eng d | ||
| 022 | _a0959-4965 | ||
| 024 | 7 |
_a10.1097/00001756-199707280-00029 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEkesbo, A | |
| 245 | 0 | 0 |
_a(-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease. _h[electronic resource] |
| 260 |
_bNeuroreport _cJul 1997 |
||
| 300 |
_a2567-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCallithrix |
| 650 | 0 | 4 |
_aCarbidopa _xtherapeutic use |
| 650 | 0 | 4 |
_aDopamine Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aLevodopa _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 | _aPosture |
| 650 | 0 | 4 | _aRaclopride |
| 650 | 0 | 4 |
_aSalicylamides _xpharmacology |
| 700 | 1 | _aAndrén, P E | |
| 700 | 1 | _aGunne, L M | |
| 700 | 1 | _aTedroff, J | |
| 773 | 0 |
_tNeuroreport _gvol. 8 _gno. 11 _gp. 2567-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001756-199707280-00029 _zAvailable from publisher's website |
| 999 |
_c9241447 _d9241447 |
||